加州太平洋生物科学公司 PACB 深 沪
等待开盘 10-14 09:30:00 美东时间
2.05
-0.050
-2.38%
华盛通- 最 高2.1369
- 今 开2.07
- 成交量 1228.69万股
- 最 低 1.99
- 昨 收 2.10
- 总市值 6.37亿
- 52周最高 3.435
- 市盈率 静 --
- 换手率 3.95%
- 52周最低 1.07
- 委 比 -89.22%
- 总股本 3.11亿
- 历史最高 53.69
- 量 比 0.53
- 振 幅 7.00%
- 历史最低 0.8511
- 每 手 1
- 风险率 0.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index surging over 250 points on Tuesday. Shares of Apogee Enterprises Inc (NASDAQ:APOG) rose sharply after the company announced better-than-expected second-quarter financial results and raised its FY27 guidance above estimates. Apogee Enterprises reporte...
10-06 21:59
期权扫描 | Gemini 4突然发布！谷歌多张Call单升逾200%；美光业绩大超预期，期权成交爆量至63万张
Gemini 4突然发布！谷歌-A多张Call单升逾200%；美光业绩大超预期，期权成交爆量至63万张>>
10-01 18:30
Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Monday. Shares of Kodiak Sciences Inc (NASDAQ:KOD) rose sharply after the company released data from the Phase 3 DAYBREAK trial for patients suffering from wet age-related macular degeneration (wAMD). The study showed that b...
09-29 02:25
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
UBS Assumes Pacific Biosciences at Neutral, Lowers Price Target of $1.35
UBS analyst Doug Schenkel assumes Pacific Biosciences (NASDAQ:PACB) with a Neutral rating and lowers Price Target of $1.35.
09-10 02:08
美股牛股 | Capricor飙近22%，获大行上调目标价至54美元；机器人股RR、稀土概念股Critical Metals双双升逾21%
Capricor隔夜飙升21.9%，获大行上调目标价至54美元；Richtech Robotics升21.6%，宣布1200万美元股票回购计划；稀土概念股Critical Metals劲升21.4%>>
08-26 19:31
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Tuesday. Shares of Nayax Ltd (NASDAQ:NYAX) rose sharply during Tuesday’s session after the payments company agreed to acquire smart parking technology provider IPS Group Inc. for $350 million in cash. Nayax will acquire ...
08-25 22:03
PacBio Restructures Operations and Appoints New CEO
Pacific Biosciences ( ($PACB) ) has shared an announcement. On July 30, 2026, P...
08-06 05:14
Pacific Biosciences Lowers FY2026 Sales Guidance from $165.000M-$175.000M to $155.000M-$165.000M vs $166.790M Est
Pacific Biosciences (NASDAQ:PACB) lowers FY2026 sales outlook from $165.000 million-$175.000 million to $155.000 million-$165.000 million vs $166.790 million estimate.
08-06 04:29
PacBio Appoints Mark Van Oene as President and Chief Executive Officer
PacBio announced that Christian Henry will transition from President and CEO, with Mark Van Oene succeeding him effective August 5, 2026. Van Oene, previously COO, has been instrumental in advancing PacBio's operational execution, commercial strategy, and AI-related product improvements. Henry will remain on the Board and serve as a business advisor. Van Oene is expected to drive PacBio's growth in clinical markets and AI-related solutions.
08-05 20:08
